FDA
approval
· 2020-05-28
FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)
Summary
The FDA approved a supplemental application for Buspirone hydrochloride (Buspirone HCl) filed by Advagen Pharma Ltd under ANDA075521, adding a generic version t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUSPIRONE HCL (BUSPIRONE HYDROCHLORIDE)